Goleta-based Sientra reported a 7% increase in sales for the second quarter of 2022 from a year earlier, but its shares were down nearly 20% the day after its Aug. 11 earnings release, likely due to a downward revision in Sientra’s full-year revenue guidance. Sientra, a breast implant manufacturer, reported a net loss of $18.3…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
